nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—pancreatic cancer	0.138	0.519	CrCtD
Daunorubicin—Doxorubicin—pancreatic cancer	0.127	0.481	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—pancreatic cancer	0.088	0.256	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Irinotecan—pancreatic cancer	0.0852	0.248	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—pancreatic cancer	0.0815	0.237	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—pancreatic cancer	0.046	0.134	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—pancreatic cancer	0.0426	0.124	CiPCiCtD
Daunorubicin—Doxorubicin—Epirubicin—pancreatic cancer	0.0294	0.173	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—pancreatic cancer	0.0294	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—pancreatic cancer	0.0294	0.173	CrCrCtD
Daunorubicin—YWHAG—Epirubicin—pancreatic cancer	0.0274	0.167	CbGbCtD
Daunorubicin—Idarubicin—Doxorubicin—pancreatic cancer	0.0272	0.16	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—pancreatic cancer	0.0272	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—pancreatic cancer	0.0272	0.16	CrCrCtD
Daunorubicin—YWHAG—Doxorubicin—pancreatic cancer	0.0146	0.0887	CbGbCtD
Daunorubicin—ABCC10—Gemcitabine—pancreatic cancer	0.00873	0.0531	CbGbCtD
Daunorubicin—POR—Doxorubicin—pancreatic cancer	0.00605	0.0368	CbGbCtD
Daunorubicin—ABCC10—Docetaxel—pancreatic cancer	0.0057	0.0347	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—pancreatic cancer	0.00557	0.0339	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—pancreatic cancer	0.00556	0.0339	CbGbCtD
Daunorubicin—CYP1B1—Tamoxifen—pancreatic cancer	0.00551	0.0335	CbGbCtD
Daunorubicin—ABCB11—Tamoxifen—pancreatic cancer	0.00551	0.0335	CbGbCtD
Daunorubicin—CYP1B1—Erlotinib—pancreatic cancer	0.00468	0.0285	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—pancreatic cancer	0.00425	0.0259	CbGbCtD
Daunorubicin—XDH—Doxorubicin—pancreatic cancer	0.00348	0.0212	CbGbCtD
Daunorubicin—CYP1B1—Docetaxel—pancreatic cancer	0.0031	0.0189	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—pancreatic cancer	0.00309	0.0188	CbGbCtD
Daunorubicin—CYP1A1—Dacarbazine—pancreatic cancer	0.00304	0.0185	CbGbCtD
Daunorubicin—ABCC1—Irinotecan—pancreatic cancer	0.003	0.0183	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—pancreatic cancer	0.00296	0.018	CbGbCtD
Daunorubicin—ABCC2—Tamoxifen—pancreatic cancer	0.0029	0.0176	CbGbCtD
Daunorubicin—ABCG2—Tamoxifen—pancreatic cancer	0.00262	0.0159	CbGbCtD
Daunorubicin—ABCB11—bile duct—pancreatic cancer	0.00244	0.237	CbGeAlD
Daunorubicin—CYP1A1—Tamoxifen—pancreatic cancer	0.00242	0.0147	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—pancreatic cancer	0.00231	0.0141	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—pancreatic cancer	0.00231	0.0141	CbGbCtD
Daunorubicin—ABCG2—Erlotinib—pancreatic cancer	0.00223	0.0136	CbGbCtD
Daunorubicin—ABCC2—Irinotecan—pancreatic cancer	0.00222	0.0135	CbGbCtD
Daunorubicin—ABCC1—Docetaxel—pancreatic cancer	0.0022	0.0134	CbGbCtD
Daunorubicin—CYP1A1—Erlotinib—pancreatic cancer	0.00205	0.0125	CbGbCtD
Daunorubicin—ABCG2—Irinotecan—pancreatic cancer	0.00201	0.0122	CbGbCtD
Daunorubicin—ABCG2—Fluorouracil—pancreatic cancer	0.00193	0.0117	CbGbCtD
Daunorubicin—ABCB11—bile—pancreatic cancer	0.00187	0.182	CbGeAlD
Daunorubicin—ABCC1—Doxorubicin—pancreatic cancer	0.00164	0.00999	CbGbCtD
Daunorubicin—ABCC2—Docetaxel—pancreatic cancer	0.00163	0.00992	CbGbCtD
Daunorubicin—ABCC2—Sunitinib—pancreatic cancer	0.00162	0.00988	CbGbCtD
Daunorubicin—ABCG2—Docetaxel—pancreatic cancer	0.00147	0.00897	CbGbCtD
Daunorubicin—ABCG2—Sunitinib—pancreatic cancer	0.00147	0.00893	CbGbCtD
Daunorubicin—CYP3A5—Tamoxifen—pancreatic cancer	0.00145	0.00883	CbGbCtD
Daunorubicin—CYP1A2—Dacarbazine—pancreatic cancer	0.00136	0.00826	CbGbCtD
Daunorubicin—ABCC2—bile duct—pancreatic cancer	0.00124	0.12	CbGeAlD
Daunorubicin—CYP3A5—Erlotinib—pancreatic cancer	0.00123	0.00751	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—pancreatic cancer	0.00121	0.0074	CbGbCtD
Daunorubicin—CYP3A5—Irinotecan—pancreatic cancer	0.00111	0.00678	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—pancreatic cancer	0.0011	0.00669	CbGbCtD
Daunorubicin—CYP1A2—Tamoxifen—pancreatic cancer	0.00108	0.00657	CbGbCtD
Daunorubicin—ABCC2—bile—pancreatic cancer	0.000952	0.0925	CbGeAlD
Daunorubicin—ABCB1—Tamoxifen—pancreatic cancer	0.000944	0.00575	CbGbCtD
Daunorubicin—CYP1A2—Erlotinib—pancreatic cancer	0.000918	0.00559	CbGbCtD
Daunorubicin—CYP3A5—Docetaxel—pancreatic cancer	0.000816	0.00497	CbGbCtD
Daunorubicin—ABCB1—Gemcitabine—pancreatic cancer	0.000813	0.00495	CbGbCtD
Daunorubicin—CYP3A5—Sunitinib—pancreatic cancer	0.000812	0.00495	CbGbCtD
Daunorubicin—ABCB1—Erlotinib—pancreatic cancer	0.000803	0.00489	CbGbCtD
Daunorubicin—CYP1A2—Fluorouracil—pancreatic cancer	0.000795	0.00484	CbGbCtD
Daunorubicin—ABCB1—Irinotecan—pancreatic cancer	0.000725	0.00441	CbGbCtD
Daunorubicin—CYP3A4—Tamoxifen—pancreatic cancer	0.000565	0.00344	CbGbCtD
Daunorubicin—ABCB1—Docetaxel—pancreatic cancer	0.000531	0.00323	CbGbCtD
Daunorubicin—ABCB1—Sunitinib—pancreatic cancer	0.000529	0.00322	CbGbCtD
Daunorubicin—CYP3A4—Erlotinib—pancreatic cancer	0.000481	0.00293	CbGbCtD
Daunorubicin—TOP2B—Topotecan—Irinotecan—pancreatic cancer	0.000473	0.625	CbGdCrCtD
Daunorubicin—CYP3A4—Irinotecan—pancreatic cancer	0.000434	0.00264	CbGbCtD
Daunorubicin—ABCB1—Doxorubicin—pancreatic cancer	0.000396	0.00241	CbGbCtD
Daunorubicin—NR5A1—pancreas—pancreatic cancer	0.00038	0.037	CbGeAlD
Daunorubicin—YWHAG—islet of Langerhans—pancreatic cancer	0.000358	0.0347	CbGeAlD
Daunorubicin—TOP2B—islet of Langerhans—pancreatic cancer	0.000345	0.0335	CbGeAlD
Daunorubicin—CYP3A4—Docetaxel—pancreatic cancer	0.000318	0.00194	CbGbCtD
Daunorubicin—CYP3A4—Sunitinib—pancreatic cancer	0.000317	0.00193	CbGbCtD
Daunorubicin—POR—islet of Langerhans—pancreatic cancer	0.000272	0.0264	CbGeAlD
Daunorubicin—YWHAG—pancreas—pancreatic cancer	0.000251	0.0244	CbGeAlD
Daunorubicin—TOP2B—pancreas—pancreatic cancer	0.000242	0.0235	CbGeAlD
Daunorubicin—CYP3A4—Doxorubicin—pancreatic cancer	0.000237	0.00144	CbGbCtD
Daunorubicin—YWHAG—digestive system—pancreatic cancer	0.000215	0.0209	CbGeAlD
Daunorubicin—XDH—digestive system—pancreatic cancer	0.000209	0.0203	CbGeAlD
Daunorubicin—TOP2B—digestive system—pancreatic cancer	0.000207	0.0201	CbGeAlD
Daunorubicin—ABCB11—digestive system—pancreatic cancer	0.000205	0.0199	CbGeAlD
Daunorubicin—SLC22A2—digestive system—pancreatic cancer	0.000164	0.0159	CbGeAlD
Daunorubicin—ABCC10—digestive system—pancreatic cancer	0.00013	0.0126	CbGeAlD
Daunorubicin—CYP3A5—islet of Langerhans—pancreatic cancer	0.000117	0.0114	CbGeAlD
Daunorubicin—ABCC2—digestive system—pancreatic cancer	0.000104	0.0101	CbGeAlD
Daunorubicin—CYP1B1—digestive system—pancreatic cancer	0.000102	0.00989	CbGeAlD
Daunorubicin—CYP3A5—pancreas—pancreatic cancer	8.24e-05	0.00801	CbGeAlD
Daunorubicin—TOP2A—Topotecan—Irinotecan—pancreatic cancer	7.65e-05	0.101	CbGdCrCtD
Daunorubicin—CYP1A2—digestive system—pancreatic cancer	7.3e-05	0.00709	CbGeAlD
Daunorubicin—CYP1A1—digestive system—pancreatic cancer	7.2e-05	0.00699	CbGeAlD
Daunorubicin—CYP3A5—digestive system—pancreatic cancer	7.04e-05	0.00684	CbGeAlD
Daunorubicin—ABCB1—islet of Langerhans—pancreatic cancer	6.23e-05	0.00605	CbGeAlD
Daunorubicin—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	5.37e-05	0.0708	CbGdCrCtD
Daunorubicin—CYP3A4—digestive system—pancreatic cancer	5.28e-05	0.00513	CbGeAlD
Daunorubicin—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	5.15e-05	0.068	CbGdCrCtD
Daunorubicin—ABCB1—pancreas—pancreatic cancer	4.38e-05	0.00425	CbGeAlD
Daunorubicin—ABCB1—digestive system—pancreatic cancer	3.74e-05	0.00363	CbGeAlD
Daunorubicin—Affect lability—Doxorubicin—pancreatic cancer	2.04e-05	0.000583	CcSEcCtD
Daunorubicin—Fatigue—Irinotecan—pancreatic cancer	2.04e-05	0.000581	CcSEcCtD
Daunorubicin—Alopecia—Docetaxel—pancreatic cancer	2.03e-05	0.00058	CcSEcCtD
Daunorubicin—Pruritus—Sunitinib—pancreatic cancer	2.03e-05	0.000579	CcSEcCtD
Daunorubicin—Pain—Irinotecan—pancreatic cancer	2.02e-05	0.000577	CcSEcCtD
Daunorubicin—Constipation—Irinotecan—pancreatic cancer	2.02e-05	0.000577	CcSEcCtD
Daunorubicin—Dyspnoea—Fluorouracil—pancreatic cancer	2.02e-05	0.000576	CcSEcCtD
Daunorubicin—Somnolence—Fluorouracil—pancreatic cancer	2.01e-05	0.000574	CcSEcCtD
Daunorubicin—Erythema—Docetaxel—pancreatic cancer	2e-05	0.000571	CcSEcCtD
Daunorubicin—Decreased appetite—Gemcitabine—pancreatic cancer	2e-05	0.000571	CcSEcCtD
Daunorubicin—Nausea—Tamoxifen—pancreatic cancer	1.99e-05	0.000568	CcSEcCtD
Daunorubicin—Fatigue—Gemcitabine—pancreatic cancer	1.98e-05	0.000566	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—pancreatic cancer	1.98e-05	0.000566	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—pancreatic cancer	1.97e-05	0.000563	CcSEcCtD
Daunorubicin—Pain—Gemcitabine—pancreatic cancer	1.97e-05	0.000562	CcSEcCtD
Daunorubicin—Constipation—Gemcitabine—pancreatic cancer	1.97e-05	0.000562	CcSEcCtD
Daunorubicin—Nausea—Erlotinib—pancreatic cancer	1.97e-05	0.000562	CcSEcCtD
Daunorubicin—Decreased appetite—Fluorouracil—pancreatic cancer	1.97e-05	0.000561	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—pancreatic cancer	1.96e-05	0.000561	CcSEcCtD
Daunorubicin—Diarrhoea—Sunitinib—pancreatic cancer	1.96e-05	0.00056	CcSEcCtD
Daunorubicin—Dysgeusia—Docetaxel—pancreatic cancer	1.96e-05	0.000559	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—pancreatic cancer	1.95e-05	0.000557	CcSEcCtD
Daunorubicin—Feeling abnormal—Irinotecan—pancreatic cancer	1.95e-05	0.000556	CcSEcCtD
Daunorubicin—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	1.94e-05	0.0256	CbGdCrCtD
Daunorubicin—Dysphagia—Epirubicin—pancreatic cancer	1.94e-05	0.000553	CcSEcCtD
Daunorubicin—Back pain—Docetaxel—pancreatic cancer	1.93e-05	0.000553	CcSEcCtD
Daunorubicin—Pain—Fluorouracil—pancreatic cancer	1.93e-05	0.000552	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Irinotecan—pancreatic cancer	1.93e-05	0.000551	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—pancreatic cancer	1.93e-05	0.00055	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—pancreatic cancer	1.9e-05	0.000543	CcSEcCtD
Daunorubicin—Dizziness—Sunitinib—pancreatic cancer	1.9e-05	0.000541	CcSEcCtD
Daunorubicin—Feeling abnormal—Gemcitabine—pancreatic cancer	1.9e-05	0.000541	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—pancreatic cancer	1.89e-05	0.000539	CcSEcCtD
Daunorubicin—Abdominal pain—Irinotecan—pancreatic cancer	1.87e-05	0.000533	CcSEcCtD
Daunorubicin—Body temperature increased—Irinotecan—pancreatic cancer	1.87e-05	0.000533	CcSEcCtD
Daunorubicin—Feeling abnormal—Fluorouracil—pancreatic cancer	1.86e-05	0.000532	CcSEcCtD
Daunorubicin—Anaemia—Docetaxel—pancreatic cancer	1.85e-05	0.000528	CcSEcCtD
Daunorubicin—Pancytopenia—Epirubicin—pancreatic cancer	1.84e-05	0.000525	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—pancreatic cancer	1.83e-05	0.000524	CcSEcCtD
Daunorubicin—Vomiting—Sunitinib—pancreatic cancer	1.82e-05	0.000521	CcSEcCtD
Daunorubicin—Body temperature increased—Gemcitabine—pancreatic cancer	1.82e-05	0.000519	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—pancreatic cancer	1.81e-05	0.000517	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—pancreatic cancer	1.81e-05	0.000517	CcSEcCtD
Daunorubicin—Rash—Sunitinib—pancreatic cancer	1.81e-05	0.000516	CcSEcCtD
Daunorubicin—Dermatitis—Sunitinib—pancreatic cancer	1.81e-05	0.000516	CcSEcCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	1.8e-05	0.0237	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	1.8e-05	0.0237	CbGdCrCtD
Daunorubicin—Urticaria—Fluorouracil—pancreatic cancer	1.8e-05	0.000513	CcSEcCtD
Daunorubicin—Headache—Sunitinib—pancreatic cancer	1.8e-05	0.000513	CcSEcCtD
Daunorubicin—Syncope—Docetaxel—pancreatic cancer	1.79e-05	0.000512	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—pancreatic cancer	1.79e-05	0.000512	CcSEcCtD
Daunorubicin—Leukopenia—Docetaxel—pancreatic cancer	1.79e-05	0.000511	CcSEcCtD
Daunorubicin—Body temperature increased—Fluorouracil—pancreatic cancer	1.79e-05	0.000511	CcSEcCtD
Daunorubicin—Palpitations—Docetaxel—pancreatic cancer	1.77e-05	0.000505	CcSEcCtD
Daunorubicin—Loss of consciousness—Docetaxel—pancreatic cancer	1.76e-05	0.000502	CcSEcCtD
Daunorubicin—Cough—Docetaxel—pancreatic cancer	1.75e-05	0.000498	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—pancreatic cancer	1.74e-05	0.000498	CcSEcCtD
Daunorubicin—Hypersensitivity—Irinotecan—pancreatic cancer	1.74e-05	0.000497	CcSEcCtD
Daunorubicin—Convulsion—Docetaxel—pancreatic cancer	1.73e-05	0.000495	CcSEcCtD
Daunorubicin—Hypertension—Docetaxel—pancreatic cancer	1.73e-05	0.000493	CcSEcCtD
Daunorubicin—Chest pain—Docetaxel—pancreatic cancer	1.7e-05	0.000486	CcSEcCtD
Daunorubicin—Arthralgia—Docetaxel—pancreatic cancer	1.7e-05	0.000486	CcSEcCtD
Daunorubicin—Myalgia—Docetaxel—pancreatic cancer	1.7e-05	0.000486	CcSEcCtD
Daunorubicin—Nausea—Sunitinib—pancreatic cancer	1.7e-05	0.000486	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—pancreatic cancer	1.7e-05	0.000486	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—pancreatic cancer	1.7e-05	0.000485	CcSEcCtD
Daunorubicin—Asthenia—Irinotecan—pancreatic cancer	1.69e-05	0.000484	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—pancreatic cancer	1.69e-05	0.000483	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—pancreatic cancer	1.68e-05	0.000481	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—pancreatic cancer	1.68e-05	0.000479	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—pancreatic cancer	1.68e-05	0.000478	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—pancreatic cancer	1.68e-05	0.000478	CcSEcCtD
Daunorubicin—Hypersensitivity—Fluorouracil—pancreatic cancer	1.67e-05	0.000476	CcSEcCtD
Daunorubicin—Dry mouth—Docetaxel—pancreatic cancer	1.67e-05	0.000476	CcSEcCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	1.66e-05	0.022	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	1.66e-05	0.022	CbGdCrCtD
Daunorubicin—Asthenia—Gemcitabine—pancreatic cancer	1.65e-05	0.000471	CcSEcCtD
Daunorubicin—Confusional state—Docetaxel—pancreatic cancer	1.65e-05	0.00047	CcSEcCtD
Daunorubicin—Anaphylactic shock—Docetaxel—pancreatic cancer	1.63e-05	0.000466	CcSEcCtD
Daunorubicin—Oedema—Docetaxel—pancreatic cancer	1.63e-05	0.000466	CcSEcCtD
Daunorubicin—Pruritus—Gemcitabine—pancreatic cancer	1.63e-05	0.000465	CcSEcCtD
Daunorubicin—Infection—Docetaxel—pancreatic cancer	1.62e-05	0.000463	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—pancreatic cancer	1.62e-05	0.000463	CcSEcCtD
Daunorubicin—Diarrhoea—Irinotecan—pancreatic cancer	1.62e-05	0.000461	CcSEcCtD
Daunorubicin—Shock—Docetaxel—pancreatic cancer	1.61e-05	0.000459	CcSEcCtD
Daunorubicin—Pruritus—Fluorouracil—pancreatic cancer	1.6e-05	0.000457	CcSEcCtD
Daunorubicin—Thrombocytopenia—Docetaxel—pancreatic cancer	1.6e-05	0.000456	CcSEcCtD
Daunorubicin—Tachycardia—Docetaxel—pancreatic cancer	1.59e-05	0.000455	CcSEcCtD
Daunorubicin—Diarrhoea—Gemcitabine—pancreatic cancer	1.57e-05	0.000449	CcSEcCtD
Daunorubicin—Renal failure—Doxorubicin—pancreatic cancer	1.57e-05	0.000448	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	1.57e-05	0.000447	CcSEcCtD
Daunorubicin—Dizziness—Irinotecan—pancreatic cancer	1.56e-05	0.000446	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—pancreatic cancer	1.56e-05	0.000445	CcSEcCtD
Daunorubicin—Anorexia—Docetaxel—pancreatic cancer	1.56e-05	0.000444	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—pancreatic cancer	1.55e-05	0.000444	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—pancreatic cancer	1.55e-05	0.000443	CcSEcCtD
Daunorubicin—Diarrhoea—Fluorouracil—pancreatic cancer	1.55e-05	0.000442	CcSEcCtD
Daunorubicin—Vomiting—Irinotecan—pancreatic cancer	1.5e-05	0.000429	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—pancreatic cancer	1.5e-05	0.000428	CcSEcCtD
Daunorubicin—Dizziness—Fluorouracil—pancreatic cancer	1.5e-05	0.000427	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—pancreatic cancer	1.49e-05	0.000427	CcSEcCtD
Daunorubicin—Rash—Irinotecan—pancreatic cancer	1.49e-05	0.000425	CcSEcCtD
Daunorubicin—Dermatitis—Irinotecan—pancreatic cancer	1.49e-05	0.000425	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	1.49e-05	0.000425	CcSEcCtD
Daunorubicin—Headache—Irinotecan—pancreatic cancer	1.48e-05	0.000422	CcSEcCtD
Daunorubicin—Insomnia—Docetaxel—pancreatic cancer	1.48e-05	0.000422	CcSEcCtD
Daunorubicin—Vomiting—Gemcitabine—pancreatic cancer	1.46e-05	0.000418	CcSEcCtD
Daunorubicin—Dyspnoea—Docetaxel—pancreatic cancer	1.46e-05	0.000416	CcSEcCtD
Daunorubicin—Somnolence—Docetaxel—pancreatic cancer	1.45e-05	0.000414	CcSEcCtD
Daunorubicin—Rash—Gemcitabine—pancreatic cancer	1.45e-05	0.000414	CcSEcCtD
Daunorubicin—Dermatitis—Gemcitabine—pancreatic cancer	1.45e-05	0.000414	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—pancreatic cancer	1.44e-05	0.000413	CcSEcCtD
Daunorubicin—Headache—Gemcitabine—pancreatic cancer	1.44e-05	0.000412	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—pancreatic cancer	1.44e-05	0.000411	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—pancreatic cancer	1.44e-05	0.000411	CcSEcCtD
Daunorubicin—Vomiting—Fluorouracil—pancreatic cancer	1.44e-05	0.000411	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—pancreatic cancer	1.44e-05	0.000411	CcSEcCtD
Daunorubicin—Rash—Fluorouracil—pancreatic cancer	1.43e-05	0.000407	CcSEcCtD
Daunorubicin—Dermatitis—Fluorouracil—pancreatic cancer	1.42e-05	0.000407	CcSEcCtD
Daunorubicin—Decreased appetite—Docetaxel—pancreatic cancer	1.42e-05	0.000405	CcSEcCtD
Daunorubicin—Headache—Fluorouracil—pancreatic cancer	1.42e-05	0.000405	CcSEcCtD
Daunorubicin—Fatigue—Docetaxel—pancreatic cancer	1.41e-05	0.000402	CcSEcCtD
Daunorubicin—Nausea—Irinotecan—pancreatic cancer	1.4e-05	0.000401	CcSEcCtD
Daunorubicin—Pain—Docetaxel—pancreatic cancer	1.4e-05	0.000399	CcSEcCtD
Daunorubicin—Constipation—Docetaxel—pancreatic cancer	1.4e-05	0.000399	CcSEcCtD
Daunorubicin—Chills—Epirubicin—pancreatic cancer	1.39e-05	0.000397	CcSEcCtD
Daunorubicin—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	1.39e-05	0.0183	CbGdCrCtD
Daunorubicin—Arrhythmia—Epirubicin—pancreatic cancer	1.38e-05	0.000395	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—pancreatic cancer	1.38e-05	0.000395	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—pancreatic cancer	1.37e-05	0.000391	CcSEcCtD
Daunorubicin—Nausea—Gemcitabine—pancreatic cancer	1.37e-05	0.00039	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—pancreatic cancer	1.35e-05	0.000385	CcSEcCtD
Daunorubicin—Feeling abnormal—Docetaxel—pancreatic cancer	1.35e-05	0.000384	CcSEcCtD
Daunorubicin—Nausea—Fluorouracil—pancreatic cancer	1.34e-05	0.000384	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—pancreatic cancer	1.34e-05	0.000382	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.33e-05	0.000381	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—pancreatic cancer	1.33e-05	0.00038	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—pancreatic cancer	1.33e-05	0.00038	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—pancreatic cancer	1.32e-05	0.000377	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—pancreatic cancer	1.3e-05	0.000373	CcSEcCtD
Daunorubicin—Abdominal pain—Docetaxel—pancreatic cancer	1.29e-05	0.000369	CcSEcCtD
Daunorubicin—Body temperature increased—Docetaxel—pancreatic cancer	1.29e-05	0.000369	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—pancreatic cancer	1.29e-05	0.000367	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—pancreatic cancer	1.28e-05	0.000366	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—pancreatic cancer	1.27e-05	0.000362	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—pancreatic cancer	1.25e-05	0.000357	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—pancreatic cancer	1.25e-05	0.000356	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—pancreatic cancer	1.25e-05	0.000356	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—pancreatic cancer	1.24e-05	0.000354	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—pancreatic cancer	1.22e-05	0.000349	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—pancreatic cancer	1.22e-05	0.000347	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—pancreatic cancer	1.21e-05	0.000346	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—pancreatic cancer	1.21e-05	0.000345	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—pancreatic cancer	1.21e-05	0.000345	CcSEcCtD
Daunorubicin—Hypersensitivity—Docetaxel—pancreatic cancer	1.2e-05	0.000343	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—pancreatic cancer	1.19e-05	0.00034	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—pancreatic cancer	1.19e-05	0.000339	CcSEcCtD
Daunorubicin—Cough—Epirubicin—pancreatic cancer	1.18e-05	0.000336	CcSEcCtD
Daunorubicin—Asthenia—Docetaxel—pancreatic cancer	1.17e-05	0.000334	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—pancreatic cancer	1.17e-05	0.000334	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—pancreatic cancer	1.16e-05	0.000333	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.16e-05	0.000331	CcSEcCtD
Daunorubicin—Pruritus—Docetaxel—pancreatic cancer	1.15e-05	0.00033	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—pancreatic cancer	1.15e-05	0.000329	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—pancreatic cancer	1.15e-05	0.000328	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—pancreatic cancer	1.15e-05	0.000328	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—pancreatic cancer	1.15e-05	0.000328	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—pancreatic cancer	1.15e-05	0.000328	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—pancreatic cancer	1.14e-05	0.000327	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—pancreatic cancer	1.13e-05	0.000324	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—pancreatic cancer	1.13e-05	0.000321	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—pancreatic cancer	1.12e-05	0.000321	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—pancreatic cancer	1.12e-05	0.00032	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—pancreatic cancer	1.12e-05	0.000319	CcSEcCtD
Daunorubicin—Diarrhoea—Docetaxel—pancreatic cancer	1.12e-05	0.000319	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—pancreatic cancer	1.11e-05	0.000317	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—pancreatic cancer	1.1e-05	0.000315	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—pancreatic cancer	1.1e-05	0.000314	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—pancreatic cancer	1.1e-05	0.000314	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—pancreatic cancer	1.1e-05	0.000313	CcSEcCtD
Daunorubicin—Infection—Epirubicin—pancreatic cancer	1.09e-05	0.000312	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—pancreatic cancer	1.09e-05	0.000311	CcSEcCtD
Daunorubicin—Shock—Epirubicin—pancreatic cancer	1.08e-05	0.000309	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—pancreatic cancer	1.08e-05	0.000309	CcSEcCtD
Daunorubicin—Dizziness—Docetaxel—pancreatic cancer	1.08e-05	0.000308	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—pancreatic cancer	1.08e-05	0.000308	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—pancreatic cancer	1.08e-05	0.000308	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—pancreatic cancer	1.07e-05	0.000307	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—pancreatic cancer	1.06e-05	0.000304	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—pancreatic cancer	1.06e-05	0.000303	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—pancreatic cancer	1.06e-05	0.000303	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—pancreatic cancer	1.06e-05	0.000303	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—pancreatic cancer	1.06e-05	0.000302	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—pancreatic cancer	1.05e-05	0.0003	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—pancreatic cancer	1.05e-05	0.0003	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—pancreatic cancer	1.04e-05	0.000297	CcSEcCtD
Daunorubicin—Vomiting—Docetaxel—pancreatic cancer	1.04e-05	0.000296	CcSEcCtD
Daunorubicin—Rash—Docetaxel—pancreatic cancer	1.03e-05	0.000294	CcSEcCtD
Daunorubicin—Dermatitis—Docetaxel—pancreatic cancer	1.03e-05	0.000294	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—pancreatic cancer	1.03e-05	0.000293	CcSEcCtD
Daunorubicin—Headache—Docetaxel—pancreatic cancer	1.02e-05	0.000292	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.02e-05	0.000291	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—pancreatic cancer	1.02e-05	0.000291	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—pancreatic cancer	1.01e-05	0.000289	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1e-05	0.000286	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—pancreatic cancer	1e-05	0.000286	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.97e-06	0.000285	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—pancreatic cancer	9.96e-06	0.000284	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—pancreatic cancer	9.94e-06	0.000284	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.85e-06	0.000281	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—pancreatic cancer	9.82e-06	0.00028	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—pancreatic cancer	9.79e-06	0.00028	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—pancreatic cancer	9.71e-06	0.000277	CcSEcCtD
Daunorubicin—Nausea—Docetaxel—pancreatic cancer	9.7e-06	0.000277	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—pancreatic cancer	9.57e-06	0.000273	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—pancreatic cancer	9.49e-06	0.000271	CcSEcCtD
Daunorubicin—Pain—Epirubicin—pancreatic cancer	9.41e-06	0.000269	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—pancreatic cancer	9.41e-06	0.000269	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.28e-06	0.000265	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—pancreatic cancer	9.21e-06	0.000263	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—pancreatic cancer	9.08e-06	0.000259	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—pancreatic cancer	9.07e-06	0.000259	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—pancreatic cancer	9.06e-06	0.000259	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—pancreatic cancer	9e-06	0.000257	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—pancreatic cancer	8.86e-06	0.000253	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—pancreatic cancer	8.78e-06	0.000251	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—pancreatic cancer	8.75e-06	0.00025	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—pancreatic cancer	8.71e-06	0.000249	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—pancreatic cancer	8.71e-06	0.000249	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—pancreatic cancer	8.7e-06	0.000249	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—pancreatic cancer	8.7e-06	0.000249	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—pancreatic cancer	8.39e-06	0.00024	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.33e-06	0.000238	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—pancreatic cancer	8.11e-06	0.000232	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—pancreatic cancer	8.09e-06	0.000231	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—pancreatic cancer	8.05e-06	0.00023	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—pancreatic cancer	8.05e-06	0.00023	CcSEcCtD
Daunorubicin—Asthenia—Epirubicin—pancreatic cancer	7.9e-06	0.000226	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—pancreatic cancer	7.79e-06	0.000222	CcSEcCtD
Daunorubicin—Diarrhoea—Epirubicin—pancreatic cancer	7.53e-06	0.000215	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—pancreatic cancer	7.51e-06	0.000214	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—pancreatic cancer	7.31e-06	0.000209	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—pancreatic cancer	7.28e-06	0.000208	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—pancreatic cancer	7.21e-06	0.000206	CcSEcCtD
Daunorubicin—Vomiting—Epirubicin—pancreatic cancer	7e-06	0.0002	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—pancreatic cancer	6.97e-06	0.000199	CcSEcCtD
Daunorubicin—Rash—Epirubicin—pancreatic cancer	6.94e-06	0.000198	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—pancreatic cancer	6.94e-06	0.000198	CcSEcCtD
Daunorubicin—Headache—Epirubicin—pancreatic cancer	6.9e-06	0.000197	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—pancreatic cancer	6.74e-06	0.000192	CcSEcCtD
Daunorubicin—Nausea—Epirubicin—pancreatic cancer	6.54e-06	0.000187	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—pancreatic cancer	6.48e-06	0.000185	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—pancreatic cancer	6.42e-06	0.000183	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—pancreatic cancer	6.42e-06	0.000183	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—pancreatic cancer	6.38e-06	0.000182	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—pancreatic cancer	6.05e-06	0.000173	CcSEcCtD
Daunorubicin—CYP1B1—Metabolism—SLC2A2—pancreatic cancer	3.12e-06	0.000282	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ARG2—pancreatic cancer	3.1e-06	0.000279	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—pancreatic cancer	3.09e-06	0.000279	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.09e-06	0.000279	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.09e-06	0.000278	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GLP1R—pancreatic cancer	3.05e-06	0.000275	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GLP1R—pancreatic cancer	3.01e-06	0.000272	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—STK11—pancreatic cancer	3e-06	0.000271	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—DPYD—pancreatic cancer	3e-06	0.00027	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD44—pancreatic cancer	2.99e-06	0.000269	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.98e-06	0.000269	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HSPA1A—pancreatic cancer	2.97e-06	0.000267	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—DPYD—pancreatic cancer	2.97e-06	0.000267	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—pancreatic cancer	2.95e-06	0.000266	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ARG2—pancreatic cancer	2.93e-06	0.000264	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—APOE—pancreatic cancer	2.85e-06	0.000257	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.84e-06	0.000256	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.82e-06	0.000254	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	2.81e-06	0.000254	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.81e-06	0.000253	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.78e-06	0.00025	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.77e-06	0.000249	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.72e-06	0.000245	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMP—pancreatic cancer	2.71e-06	0.000244	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.7e-06	0.000243	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—pancreatic cancer	2.64e-06	0.000238	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—pancreatic cancer	2.58e-06	0.000233	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TYMS—pancreatic cancer	2.58e-06	0.000233	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CG—pancreatic cancer	2.57e-06	0.000232	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.57e-06	0.000231	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMP—pancreatic cancer	2.56e-06	0.000231	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CD44—pancreatic cancer	2.5e-06	0.000226	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.5e-06	0.000225	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PPARG—pancreatic cancer	2.48e-06	0.000224	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.47e-06	0.000223	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.45e-06	0.000221	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.43e-06	0.000219	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CD44—pancreatic cancer	2.42e-06	0.000218	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.41e-06	0.000217	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GCG—pancreatic cancer	2.4e-06	0.000216	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.37e-06	0.000214	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SMAD4—pancreatic cancer	2.36e-06	0.000213	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.35e-06	0.000212	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ARG2—pancreatic cancer	2.34e-06	0.000211	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GCG—pancreatic cancer	2.32e-06	0.000209	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HES1—pancreatic cancer	2.3e-06	0.000208	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CD—pancreatic cancer	2.26e-06	0.000204	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—STK11—pancreatic cancer	2.26e-06	0.000203	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.24e-06	0.000202	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CD44—pancreatic cancer	2.2e-06	0.000198	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GLP1R—pancreatic cancer	2.18e-06	0.000197	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—STK11—pancreatic cancer	2.18e-06	0.000197	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CD44—pancreatic cancer	2.18e-06	0.000196	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.18e-06	0.000196	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—pancreatic cancer	2.16e-06	0.000195	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PRSS1—pancreatic cancer	2.15e-06	0.000194	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—DPYD—pancreatic cancer	2.15e-06	0.000194	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—pancreatic cancer	2.13e-06	0.000192	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.12e-06	0.000191	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GCG—pancreatic cancer	2.11e-06	0.00019	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.11e-06	0.00019	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—APOE—pancreatic cancer	2.1e-06	0.000189	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GCG—pancreatic cancer	2.09e-06	0.000188	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GLP1R—pancreatic cancer	2.06e-06	0.000186	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.05e-06	0.000185	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMP—pancreatic cancer	2.04e-06	0.000184	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	2.04e-06	0.000184	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—DPYD—pancreatic cancer	2.03e-06	0.000183	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TERT—pancreatic cancer	2.02e-06	0.000182	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2e-06	0.000181	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2e-06	0.00018	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.99e-06	0.000179	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—STK11—pancreatic cancer	1.98e-06	0.000179	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CB—pancreatic cancer	1.97e-06	0.000178	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—STK11—pancreatic cancer	1.96e-06	0.000177	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.96e-06	0.000177	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—pancreatic cancer	1.95e-06	0.000176	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TYMS—pancreatic cancer	1.94e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HIF1A—pancreatic cancer	1.93e-06	0.000174	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TSC2—pancreatic cancer	1.93e-06	0.000174	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.92e-06	0.000173	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.9e-06	0.000172	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CG—pancreatic cancer	1.9e-06	0.000171	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APOE—pancreatic cancer	1.88e-06	0.00017	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TYMS—pancreatic cancer	1.88e-06	0.000169	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.87e-06	0.000168	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.87e-06	0.000168	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.85e-06	0.000167	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.84e-06	0.000166	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPARG—pancreatic cancer	1.83e-06	0.000165	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOTCH1—pancreatic cancer	1.74e-06	0.000157	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TYMS—pancreatic cancer	1.71e-06	0.000154	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—pancreatic cancer	1.7e-06	0.000153	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.7e-06	0.000153	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TYMS—pancreatic cancer	1.69e-06	0.000152	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGF—pancreatic cancer	1.68e-06	0.000152	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.67e-06	0.000151	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CD—pancreatic cancer	1.67e-06	0.00015	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.66e-06	0.00015	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.65e-06	0.000148	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.65e-06	0.000148	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.63e-06	0.000147	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—DPYD—pancreatic cancer	1.62e-06	0.000146	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—APOE—pancreatic cancer	1.58e-06	0.000142	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CD44—pancreatic cancer	1.58e-06	0.000142	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.54e-06	0.000139	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—APOE—pancreatic cancer	1.53e-06	0.000138	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GCG—pancreatic cancer	1.51e-06	0.000136	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CD—pancreatic cancer	1.49e-06	0.000135	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.49e-06	0.000135	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CD44—pancreatic cancer	1.49e-06	0.000134	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.46e-06	0.000132	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CB—pancreatic cancer	1.45e-06	0.000131	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.45e-06	0.00013	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.44e-06	0.00013	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.44e-06	0.00013	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—pancreatic cancer	1.44e-06	0.00013	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GCG—pancreatic cancer	1.43e-06	0.000129	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CG—pancreatic cancer	1.42e-06	0.000128	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—STK11—pancreatic cancer	1.42e-06	0.000128	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.39e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOE—pancreatic cancer	1.39e-06	0.000125	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	1.38e-06	0.000124	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—pancreatic cancer	1.37e-06	0.000124	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOE—pancreatic cancer	1.37e-06	0.000124	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.35e-06	0.000121	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—STK11—pancreatic cancer	1.34e-06	0.000121	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—pancreatic cancer	1.33e-06	0.00012	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.31e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CB—pancreatic cancer	1.3e-06	0.000117	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.29e-06	0.000117	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—pancreatic cancer	1.29e-06	0.000116	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.26e-06	0.000114	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.26e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—pancreatic cancer	1.26e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.25e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CD—pancreatic cancer	1.25e-06	0.000113	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	1.24e-06	0.000112	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.23e-06	0.000111	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.22e-06	0.00011	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.21e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	1.21e-06	0.000109	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—pancreatic cancer	1.21e-06	0.000109	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—pancreatic cancer	1.2e-06	0.000108	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—pancreatic cancer	1.2e-06	0.000108	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CD44—pancreatic cancer	1.19e-06	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.17e-06	0.000106	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMS—pancreatic cancer	1.16e-06	0.000104	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—pancreatic cancer	1.16e-06	0.000104	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GCG—pancreatic cancer	1.14e-06	0.000103	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—pancreatic cancer	1.13e-06	0.000102	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.1e-06	9.93e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CB—pancreatic cancer	1.09e-06	9.84e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	1.09e-06	9.83e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—pancreatic cancer	1.08e-06	9.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—STK11—pancreatic cancer	1.07e-06	9.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.07e-06	9.62e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	1.06e-06	9.51e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—pancreatic cancer	1.05e-06	9.43e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—pancreatic cancer	1.04e-06	9.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.01e-06	9.15e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—pancreatic cancer	1.01e-06	9.08e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—pancreatic cancer	1e-06	9.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.98e-07	9e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOE—pancreatic cancer	9.95e-07	8.97e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—pancreatic cancer	9.81e-07	8.85e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CB—pancreatic cancer	9.6e-07	8.66e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—pancreatic cancer	9.51e-07	8.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CD44—pancreatic cancer	9.5e-07	8.57e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	9.5e-07	8.57e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.47e-07	8.54e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—pancreatic cancer	9.43e-07	8.5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—pancreatic cancer	9.42e-07	8.49e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOE—pancreatic cancer	9.4e-07	8.47e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—pancreatic cancer	9.36e-07	8.44e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—pancreatic cancer	9.33e-07	8.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.31e-07	8.39e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMS—pancreatic cancer	9.23e-07	8.32e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.22e-07	8.31e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—pancreatic cancer	9.15e-07	8.25e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—pancreatic cancer	9.12e-07	8.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GCG—pancreatic cancer	9.11e-07	8.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	8.98e-07	8.09e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.9e-07	8.02e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—pancreatic cancer	8.85e-07	7.98e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—pancreatic cancer	8.66e-07	7.81e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—pancreatic cancer	8.65e-07	7.79e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—STK11—pancreatic cancer	8.57e-07	7.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	8.48e-07	7.65e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—pancreatic cancer	8.3e-07	7.48e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—pancreatic cancer	8.21e-07	7.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—pancreatic cancer	8.19e-07	7.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.04e-07	7.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—pancreatic cancer	7.94e-07	7.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	7.89e-07	7.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOE—pancreatic cancer	7.51e-07	6.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	7.46e-07	6.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMS—pancreatic cancer	7.37e-07	6.64e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—pancreatic cancer	7.35e-07	6.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CD44—pancreatic cancer	7.33e-07	6.61e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—pancreatic cancer	7.23e-07	6.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GCG—pancreatic cancer	7.03e-07	6.34e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	6.88e-07	6.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—pancreatic cancer	6.82e-07	6.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.77e-07	6.11e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—pancreatic cancer	6.65e-07	6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—STK11—pancreatic cancer	6.61e-07	5.96e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—pancreatic cancer	6.54e-07	5.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	6.5e-07	5.86e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—pancreatic cancer	6.49e-07	5.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—pancreatic cancer	6.44e-07	5.81e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	6.43e-07	5.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOE—pancreatic cancer	5.99e-07	5.4e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.96e-07	5.37e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.94e-07	5.36e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.85e-07	5.28e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	5.79e-07	5.22e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.69e-07	5.13e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.67e-07	5.11e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—pancreatic cancer	5.62e-07	5.06e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—pancreatic cancer	5.43e-07	4.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	5.41e-07	4.88e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—pancreatic cancer	5.26e-07	4.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—pancreatic cancer	5.22e-07	4.71e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.19e-07	4.68e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.14e-07	4.64e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—pancreatic cancer	4.78e-07	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.75e-07	4.29e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—pancreatic cancer	4.73e-07	4.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOE—pancreatic cancer	4.62e-07	4.17e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—pancreatic cancer	4.49e-07	4.04e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	4.19e-07	3.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.17e-07	3.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	4.14e-07	3.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	4.11e-07	3.7e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.03e-07	3.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	3.96e-07	3.57e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.67e-07	3.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.58e-07	3.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—pancreatic cancer	3.43e-07	3.09e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—pancreatic cancer	3.24e-07	2.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.2e-07	2.88e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.17e-07	2.86e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.16e-07	2.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.76e-07	2.49e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—pancreatic cancer	2.59e-07	2.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.53e-07	2.28e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.06e-07	1.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.95e-07	1.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.59e-07	1.44e-05	CbGpPWpGaD
